Abdoulaye Sene Email

VP, Translational Science . Kartos Therapeutics

Current Roles

Employees:
111
Revenue:
$17.2M
About
Kartos Therapeutics is a privately held, clinical-stage biopharmaceutical company developing a potentially best-in-class MDM2 inhibitor. Launched in 2018 by proven industry veterans, we are a passionate team based in Redwood City, California, and Bellevue, Washington. We have brought together scientists and clinicians with a deep understanding of hematology and oncology and an experienced leadership team. Together, we’re building an exciting biotechnology company with a culture defined by caring, ambition, dedication, and teamwork!
Kartos Therapeutics Address
275 Shoreline Drive
Redwood City, CA
Kartos Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.